Moïshe Liberman

9.8k total citations · 2 hit papers
151 papers, 5.0k citations indexed

About

Moïshe Liberman is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Moïshe Liberman has authored 151 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Pulmonary and Respiratory Medicine, 64 papers in Surgery and 27 papers in Oncology. Recurrent topics in Moïshe Liberman's work include Lung Cancer Diagnosis and Treatment (53 papers), Tracheal and airway disorders (38 papers) and Pleural and Pulmonary Diseases (28 papers). Moïshe Liberman is often cited by papers focused on Lung Cancer Diagnosis and Treatment (53 papers), Tracheal and airway disorders (38 papers) and Pleural and Pulmonary Diseases (28 papers). Moïshe Liberman collaborates with scholars based in Canada, United States and Japan. Moïshe Liberman's co-authors include John S. Sampalis, David S. Mulder, Nicolas V. Christou, Lloyd D. MacLean, A. Peter H. McLean, André Lavoie, Lynne Moore, Natalie Le Sage, Pasquale Ferraro and André Duranceau and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Moïshe Liberman

141 papers receiving 4.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Surgery Decreases Long-term Mortality, Morbidity, and Health Care Use in Morbidly Obese Patients

2004 947 citations John S. Sampalis, Moïshe Liberman et al. profile →
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer

2023 460 citations Heather A. Wakelee, Moïshe Liberman et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Moïshe Liberman	2.3k	1.7k	1.3k	676	583	151	5.0k
Simon Paterson‐Brown	2.7k 1.2×	1.0k 0.6×	954 0.7×	492 0.7×	803 1.4×	134	5.0k
Amir A. Ghaferi	3.6k 1.5×	1.4k 0.8×	1.1k 0.8×	1.2k 1.8×	379 0.7×	156	6.9k
Daniel L. Davenport	3.6k 1.5×	1.8k 1.0×	629 0.5×	812 1.2×	419 0.7×	205	6.1k
Scott E. Regenbogen	2.9k 1.2×	764 0.4×	894 0.7×	1.1k 1.6×	237 0.4×	123	6.0k
Selwyn O. Rogers	1.6k 0.7×	639 0.4×	760 0.6×	661 1.0×	229 0.4×	109	4.8k
H. Leon Pachter	3.8k 1.6×	985 0.6×	1.8k 1.4×	475 0.7×	136 0.2×	127	5.7k
Mehul V. Raval	3.0k 1.3×	1.0k 0.6×	976 0.7×	499 0.7×	154 0.3×	250	5.0k
Oscar D. Guillamondegui	2.8k 1.2×	781 0.5×	1.6k 1.2×	274 0.4×	123 0.2×	136	4.9k
Laurents P. S. Stassen	4.0k 1.7×	1.1k 0.6×	460 0.3×	1.4k 2.0×	272 0.5×	157	5.4k
Ryan P. Merkow	3.1k 1.3×	1.4k 0.8×	275 0.2×	1.8k 2.6×	404 0.7×	153	5.6k

Countries citing papers authored by Moïshe Liberman

Since Specialization

Citations

This map shows the geographic impact of Moïshe Liberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moïshe Liberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moïshe Liberman more than expected).

Fields of papers citing papers by Moïshe Liberman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moïshe Liberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moïshe Liberman. The network helps show where Moïshe Liberman may publish in the future.

Co-authorship network of co-authors of Moïshe Liberman

This figure shows the co-authorship network connecting the top 25 collaborators of Moïshe Liberman. A scholar is included among the top collaborators of Moïshe Liberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moïshe Liberman. Moïshe Liberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zaouter, Cédrick, Basil Nasir, Moïshe Liberman, et al.. (2025). Intercostal cryoanalgesia for acute pain after video-assisted thoracic surgery lung resection: A randomized controlled preliminary trial. Journal of Thoracic and Cardiovascular Surgery. 170(5). 1242–1251.e1.

Poder, Thomas G., et al.. (2025). Real-Time Cost Awareness in Surgical Disposables: A Multispecialty Pre-Post Trial. Journal of Medical Systems. 49(1). 25–25.

Wakelee, Heather A., Shugeng Gao, Moïshe Liberman, et al.. (2025). LBA67 Perioperative pembrolizumab in early-stage non-small- cell lung cancer (NSCLC): 5-year follow-up from KEYNOTE- 671. Annals of Oncology. 36. S1607–S1608.

Martin, Lester W., Chongtu Yang, Xiaoliang Wang, et al.. (2024). MA03.10 Association of Surgical Margin Distance, Locoregional Recurrence, and Survival Among Patients Undergoing Sublobar Resection in CALGB140503. Journal of Thoracic Oncology. 19(10). S63–S64.

Garassino, Marina Chiara, Heather A. Wakelee, Jonathan Spicer, et al.. (2024). Health-related quality of life (HRQoL) outcomes from the randomized, double-blind phase 3 KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC).. Journal of Clinical Oncology. 42(16_suppl). 8012–8012. 2 indexed citations

Spicer, Jonathan, Nicolas Girard, Mariano Provencio, et al.. (2024). Neoadjuvant nivolumab (NIVO) + chemotherapy (chemo) vs chemo in patients (pts) with resectable NSCLC: 4-year update from CheckMate 816.. Journal of Clinical Oncology. 42(17_suppl). LBA8010–LBA8010. 25 indexed citations

Nasir, Basil, Jason Weatherald, Tim Ramsay, et al.. (2024). Randomized trial of routine versus on-demand intraoperative extracorporeal membrane oxygenation in lung transplantation: A feasibility study. The Journal of Heart and Lung Transplantation. 43(6). 1005–1009. 3 indexed citations

Jones, David R., Moïshe Liberman, Terufumi Kato, et al.. (2024). OA01.03 Association of Pathologic Regression with EFS in the KEYNOTE-671 Study of Perioperative Pembrolizumab for Early-Stage NSCLC. Journal of Thoracic Oncology. 19(10). S8–S8. 5 indexed citations

Ferraro, Pasquale, Pierre Ghosn, Edwin Lafontaine, et al.. (2024). Intersurgeon variations in postoperative length of stay after video-assisted thoracoscopic surgery lobectomy. JTCVS Open. 18. 253–260. 2 indexed citations

10.

Gao, Shugeng, Moïshe Liberman, Kun Chen, et al.. (2024). 1210P Neoadjuvant pembrolizumab (pembro) or placebo (pbo) plus chemotherapy and adjuvant pembro or pbo for early stage NSCLC: Subgroup analyses of the phase III KEYNOTE-671 study. Annals of Oncology. 35. S778–S779. 1 indexed citations

11.

Desîlets, Antoine, Wiam Belkaïd, Julie Malo, et al.. (2024). CRYOVATE: A Pilot Study of Lung Cancer Cryoactivation in Combination With Immunotherapy in Advanced NSCLC. JTO Clinical and Research Reports. 5(12). 100737–100737. 2 indexed citations

12.

Wakelee, Heather A., Moïshe Liberman, Terufumi Kato, et al.. (2023). KEYNOTE-671: Randomized, double-blind, phase 3 study of pembrolizumab or placebo plus platinum-based chemotherapy followed by resection and pembrolizumab or placebo for early stage NSCLC.. Journal of Clinical Oncology. 41(17_suppl). LBA100–LBA100. 11 indexed citations

13.

Fortin, Marc, Moïshe Liberman, Antoine Delage, et al.. (2023). Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy: A Prospective Multi-Centre Agreement Clinical Trial (CAN-ICE). American Journal of Respiratory and Critical Care Medicine. 207(12). 1612–1619. 16 indexed citations

14.

Létourneau‐Guillon, Laurent, et al.. (2023). Cerebral Air Embolism Following Catheter Ablation for Atrial Fibrillation. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 51(3). 461–462.

15.

Oh, D-Y., Yelena Y. Janjigian, S-E. Al-Batran, et al.. (2023). 129O Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study. Annals of Oncology. 34. S1520–S1521. 5 indexed citations

16.

Meloche‐Dumas, Léamarie, et al.. (2019). Breast Cancer with Internal Mammary Node Metastases: A Case Presented in a Tumor Board Session and Decision Making. SHILAP Revista de lepidopterología. 156–160.

17.

Liberman, Moïshe, Christopher R. Morse, Waël C. Hanna, et al.. (2019). Prospective, multicenter, international phase 2 trial evaluating ultrasonic energy for pulmonary artery branch sealing in video-assisted thoracoscopic surgery lobectomy. Journal of Thoracic and Cardiovascular Surgery. 159(1). 301–311. 8 indexed citations

18.

Thiffault, Vicky, et al.. (2017). Pulmonary artery sealing with ultrasonic energy in open lobectomy: A phase I clinical trial. Journal of Thoracic and Cardiovascular Surgery. 153(6). 1600–1607. 8 indexed citations

19.

Liberman, Moïshe & Douglas J. Mathisen. (2009). Tailored cricoplasty: An improved modification for reconstruction in subglottic tracheal stenosis. Journal of Thoracic and Cardiovascular Surgery. 137(3). 573–579. 28 indexed citations

20.

Liberman, Moïshe, David S. Mulder, & John S. Sampalis. (2003). Increasing volume of patients at level I trauma centres: is there a need for triage modification in elderly patients with injuries of low severity?. PubMed. 46(6). 446–52. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact